HomeInsights52 Week Low Stocks

Gland Pharma Ltd 52 Week Low

Gland Pharma Ltd 52 Week Low

stocks purchased

₹ 6.3 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

34.5 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Gland Pharma Ltd

NSE: GLAND

YEARLOW

₹ 1590

Last updated on: Dec 24, 2024

Key Highlights

  • The 52 Week Low of Gland Pharma Ltd is ₹ 1590 as of 24 Dec 24 .

Company Fundamentals for Gland Pharma Ltd

No data available

Market Price of Gland Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Dec 20241779.9
23 Dec 20241766.05
20 Dec 20241769.75
19 Dec 20241775.8
18 Dec 20241763.9
17 Dec 20241751.05
16 Dec 20241731.3
13 Dec 20241748.2
12 Dec 20241778.6
11 Dec 20241775.35

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in crore

Gland Pharma Ltd News Hub

News

Gland Pharma subsidiary receives 10 observations from French drug regulator ANSM

In a regulatory filing made yesterday, the company stated that the Agence nationale de s'c...

Read more

26 Dec 2024 09:36

News

Gland Pharma rises on USFDA nod for vitamin-K deficiency drug

The product is bioequivalent and therapeutically equivalent to the reference listed drug (...

Read more

12 Dec 2024 10:06

News

Gland Pharma receives USFDA approval for Phytonadione Injectable Emulsion

Gland Pharma has received approval from the United States Food and Drug Administration (US...

Read more

11 Dec 2024 18:20

News

Gland Pharma rises on USFDA nod for ophthalmic solution

The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...

Read more

03 Dec 2024 11:05

News

Gland Pharma Ltd spurts 1.67%, rises for third straight session

Gland Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 1809....

Read more

03 Dec 2024 13:06

News

Gland Pharma soars as Q2 PAT rises 9% QoQ to Rs 282 cr

On a consolidated basis, the firm's net profit declined 15.74% to Rs 163.53 crore despite ...

Read more

05 Nov 2024 10:42

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Gland Pharma Ltd

Why is it important to track the 52-week low of Gland Pharma Ltd stocks?

Investors should monitor the 52-week low of Gland Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Gland Pharma Ltd stocks hitting a 52-week low?

Factors leading to Gland Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Gland Pharma Ltd stocks when they hit a 52-week low?

Buying Gland Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Gland Pharma Ltd stocks?

Investors should monitor the 52-week low of Gland Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Gland Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Gland Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Gland Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Gland Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Gland Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions